摘要
川崎病是一种好发于5岁以下儿童的急性自限性血管炎性疾病。静脉输注免疫球蛋白(intravenous immunoglobulin,IVIG)已经成为一种有效的治疗方案,可以有效减少心血管并发症的发生率,但目前国内外尚无儿童川崎病IVIG应用共识或临床指南。该共识是基于目前国内外关于儿童川崎病中IVIG应用的研究进展,同时参考国内外川崎病的诊疗指南,并经过制定专家充分讨论而形成。该共识对IVIG在儿童川崎病中的临床应用策略及其不良反应的防治提出了具体建议。
Kawasaki disease is an acute,self-limited vascuitis that mainly occurs in children under 5 years of age.Intravenous immunoglobulin(IVIG)has become an effective treatment regimen,which can effectively reduce the incidence of cardiovascular complications.However,there has been no consensus or clinical guidelines for the application of IVIG in children with Kawasaki disease till now.This consensus is developed based on the current research progress on the application of IVIG in children with Kawasaki disease in China and overseas,with reference to the diagnosis and treatment guidelines for Kawasaki disease in China and overseas,and the opinions of experts.This consensus provides recommendations on the clinical application strategy of IVIG in children with Kawasaki disease and the prevention and treatment of its adverse reactions.
作者
陕西省川崎病诊疗中心
陕西省儿童内科疾病临床医学研究中心
陕西省人民医院儿童病院
中国当代儿科杂志编辑委员会
全国妇幼健康研究会儿科能力建设专委会
中国医师协会儿科医师分会普儿科(全科)学组
杜忠东
焦富勇
冯迎军
Shaanxi Provincial Diagnosis and Treatment Center of Kawasaki Disease;Clinical Research Center for Childhood Diseases of Shaanxi Province;Children's Hospital of Shaanxi Provincial People's Hospital;Editorial Board of Chinese Journal of Contemporary Pediatrics;Expert Committee of Advanced Training for Pediatrician,China Maternal and Children's Health Association;General Pediatrician Group,Society of Pediatrician,Chinese Doctor Association
出处
《中国当代儿科杂志》
CAS
CSCD
北大核心
2021年第9期867-876,共10页
Chinese Journal of Contemporary Pediatrics
关键词
川崎病
自限性血管炎
静脉输注免疫球蛋白
专家共识
儿童
Kawasaki disease
Self-limitedvasculitis
Intravenous immunoglobulin
Expert consensus
Child
